CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Exploring Sulforaphane’s Role in Stroke Prevention and Treatment
Recent research from the Heart Research Institute (HRI) in Australia highlights the potential of sulforaphane, a compound found in broccoli and other cruciferous vegetables, in improving stroke treatment outcomes and offering a preventative approach. This study lookes into the natural chemical’s interaction with conventional stroke medication, presenting a new angle on dietary influence in medical conditions.
Key Points:
- Researchers at the Heart Research Institute (HRI) have discovered that sulforaphane, a compound in broccoli, might enhance the efficacy of stroke treatments.
- Sulforaphane has been observed to improve the action of tissue plasminogen activator (tPA), the primary treatment for acute ischemic stroke, which constitutes 87% of all stroke cases.
- The substance was identified during a three-year study aimed at finding natural products that could prevent blood clots, particularly in the brain.
- Sulforaphane’s benefits extend beyond clot prevention; it does not increase the risk of bleeding, a common side effect in current stroke treatments.
- Preclinical trials have shown that combining sulforaphane with tPA increases the treatment’s success rate to 60% without causing bleeding.
- The compound is activated in cruciferous vegetables only when they are cut or chewed, initiating a chemical reaction that produces sulforaphane.
- Beyond its potential in stroke treatment, sulforaphane is recognized for its antioxidant, anti-inflammatory, and anti-cancer properties.
- The next steps involve securing funding for human clinical trials with the aim of developing a new treatment that leverages sulforaphane’s properties within five years.
“We are looking for clues in nature to find this magic anti-clotting drug which can work where it’s needed but also still allow patients to have antithrombotic treatments.”
– Xuyu Liu, lead researcher
More on Stroke
